| 000 | 02014cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030740.0 | ||
| 008 | 130117s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.03.M.Sc.2012.Ze.S | ||
| 100 | 0 | _aZeinab Ahmed Nour | |
| 245 | 1 | 0 |
_aSingle nucleotide polymorphism of IL - 10 and IL - 28 B as predictors to the response of interferon therapy in HCV infected children / _cZeinab Ahmed Nour ; Supervised Olfat G. Shaker , Yasser H. Nassar , Mona Elrazki |
| 246 | 1 | 5 | _a المتنبئات للاستجابة للعلاج بانترفيرون فى الاطفال المصابة بعدوى الفيروس الكبدى الوبائى " سى IL - 28 B والانترلوكينIL - 10التحور الجينى فى النيوكلوتيد بالانترلوكين |
| 260 |
_aCairo : _bZeinab Ahmed Nour , _c2012 |
||
| 300 |
_a123P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Medical Biochemistry | ||
| 520 | _aSingle nucleotide polymorphisms (SNPs) in IL - 10 gene promoter positions - 1082 ((rs1800896), 819 (rs3021097) and - 592 (rs1800872) and IL 28B gene (rs1297860 ) in adults were shown to be associated with HCV clearance , In this study we aim to detect this association and the relation of these SNPs to treatment response prediction in Egyptian pediatric subjects with genotype 4 who received treatment with pegylated interferon (PegIFN) plus Ribavarin (responders and non - responders) | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHepatitis C virus | |
| 653 | 4 | _aInterleukin 10 | |
| 653 | 4 | _aInterleukin 28-B | |
| 700 | 0 |
_aMona Elrazki , _eSupervisor |
|
| 700 | 0 |
_aOlfat Gamil. Shaker , _eSupervisor |
|
| 700 | 0 |
_aYasser H. Nassar , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c41132 _d41132 |
||